Levodopa Pharmacokinetics in Switching from Levodopa/Carbidopa Intestinal Gel to Continuous Subcutaneous Foslevodopa/Foscarbidopa Infusion in a Patient with Parkinson's Disease: a case report

Tomonori Nukariya; Toshiki Tezuka; Shohei Okusa; Ryotaro Okochi; Yuto Sakai; Yoshihiro Nihei; Jin Nakahara; Morinobu Seki

doi:10.14802/jmd.24247

Letter to the editor Levodopa Pharmacokinetics in Switching from Levodopa/Carbidopa Intestinal Gel to Continuous Subcutaneous Foslevodopa/Foscarbidopa Infusion in a Patient with Parkinson's Disease: a case report: Tomonori Nukariya^1,2,3, Toshiki Tezuka^1,2,3, Shohei Okusa^1,2,3, Ryotaro Okochi^1,2,3, Yuto Sakai^1,2,3, Yoshihiro Nihei^1,2,3, Jin Nakahara^1,2,3, Morinobu Seki^1,2,3; DOI: https://doi.org/10.14802/jmd.24247 [Accepted]
Published online: January 6, 2025

338 Views
78 Download
0 Crossref
0 Scopus

¹Department of Neurology, Keio University School of Medicine, Tokyo, Japan
²Parkinson’s Disease Center, Keio University Hospital, Tokyo, Japan
³Center for Parkinson's disease Research, Keio University, Tokyo, Japan

Corresponding author: Morinobu Seki,
Email: sekimori@keio.jp

Received: 28 November 2024 • Revised: 31 December 2024 • Accepted: 6 January 2025